• Journal Article

Costs and benefits of rivastigmine treatment for Alzheimer's disease in the US

Citation

Ofman, J., Hauber, A., Deal, L., Mauskopf, J., & Snyder, E. (2002). Costs and benefits of rivastigmine treatment for Alzheimer's disease in the US. Neurobiology of Aging, 23(1), 476.

Abstract